<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Genetic Disruption Sh3pxd2a Gene Reveals an <br /> Essential Role Mouse Development Existence <br /> of Novel Isoform Tks5 <br /> Pilar Cejudo-Martin1, Angela Yuen1&#194;&#164;a, Nicole Vlahovich1&#194;&#164;b, Peter Lock2, Sara A. Courtneidge1*&#194;&#164;c, <br /> Begon&#203;&#339;a D&#196;&#177;&#194;&#180;az1* <br /> 1 Cancer Center, Tumor Microenvironment Metastasis Program, Sanford-Burnham Medical Research Institute, La Jolla, California, United States America, 2 La Trobe <br /> Institute Molecular Science, La Trobe University, Victoria, Australia <br />  <br />  <br />  <br />      <span id='am-1' about='protege:abstract' typeof='owl:Thing'>Abstract</span> <br />      Tks5 scaffold protein Src substrate involved cell migration matrix degradation essential role in <br />      invadosome formation function. We previously described Tks5 fundamental zebrafish neural crest cell <br />      migration vivo. In present study, sought investigate function Tks5 mammalian development by <br />      analyzing mice mutant sh3pxd2a, gene encoding Tks5. Homozygous disruption sh3pxd2a gene gene- <br />      trapping mouse resulted neonatal death presence complete cleft secondary palate. Interestingly, <br />      embryonic fibroblasts homozygous gene-trap sh3pxd2a mice lacked highest molecular weight band the <br />      characteristic Tks5 triplet observed protein extracts, leaving lower molecular weight bands unaffected. This finding, <br />      existence human Expressed Sequence Tags lacking 5 exons SH3PXD2A, us <br />      hypothesize presence second alternative transcription start site located intron V. We performed 59RACE on <br />      mouse fibroblasts isolated new transcript sh3pxd2a gene encoding novel Tks5 isoform, named Tks5b. <br />      This novel isoform diverges long form Tks5 lacks PX-domain, confers affinity for <br />      phosphatidylinositol-3,4-bisphosphate. Instead, Tks5b short unique amino terminal sequence encoded newly <br />      discovered exon 6b; exon includes start codon located 29 bp 5&#226;&#8364;&#8482;-end exon 6. Tks5b mRNA expressed in <br />      MEFs mouse adult tissues analyzed. Tks5b substrate Src tyrosine kinase expression regulated <br />      proteasome degradation pathway. Together, findings indicate essentiality larger Tks5 isoform <br />      correct mammalian development transcriptional complexity sh3pxd2a gene. <br />  <br />   Citation: Cejudo-Martin P, Yuen A, Vlahovich N, Lock P, Courtneidge SA, et al. (2014) Genetic Disruption Sh3pxd2a Gene Reveals Essential Role Mouse <br />   Development Existence Novel Isoform Tks5. PLoS ONE 9(9): e107674. doi:10.1371/journal.pone.0107674 <br />   Editor: Vincenzo Coppola, Ohio State University Comprehensive Cancer Center, United States America <br />   Received May 15, 2014; Accepted August 12, 2014; Published September 26, 2014 <br />   Copyright: &#195;&#376; 2014 Cejudo-Martin et al. This open-access article distributed terms Creative Commons Attribution License, permits <br />   unrestricted use, distribution, reproduction medium, provided original author source credited. <br />   Data Availability: The authors confirm data underlying findings fully available restriction. All relevant data paper. <br />   Funding: This work supported National Cancer Institute CA098383 SAC, National Cancer Institute CA129686 SAC, Beatriu Pinos postdoctoral <br />   fellowship government Catalonia, Spain 2007 BPA69 PCM. The funders role study design, data collection analysis, decision publish, or <br />   preparation manuscript. <br />   Competing Interests: The authors declared competing interests exist. <br />   * Email: courtneidge@ohsu.edu (SAC); bdiaz@sbmri.org (BD) <br />   &#194;&#164;a Current address: Roseman University Health Sciences, College Pharmacy, Henderson, Nevada, United States America <br />   &#194;&#164;b Current address: Australian Sports Commission, Australian Institute Sport, Canberra, Australia <br />   &#194;&#164;c Current address: Department Cell, Developmental Cancer Biology, Oregon Health &amp; Science University, Portland, Oregon, United States America <br />  <br />  <br />  <br /> Introduction                                                                           developmental regulation genome correlation <span id='am-6' about='protege:TO' typeof='owl:Thing'>to</span> <br />                                                                                        human disease. For instance, according Online Mendelian <br />    Genetic regulation embryonic development complex                            Inheritance Man database (http://www.ncbi.nlm.nih.gov/ <br /> process underlies and, time, controlled by,                        omim, April 2014), 752 congenital diseases Mendelian <br /> specific molecular cellular changes exquisitely coordinated                     nature, suspected Mendelian basis, molecular <br /> space time. During 3 decades, development                          cause unknown. Although diseases rare the <br /> forward reverse genetics use model organisms                        population, frequent inborn developmental errors <br /> such Drosophila melanogaster, Caenorhabditis elegans, zebrafish                     non-Mendelian inheritance polygenic origin is <br /> and mouse allowed <span id='am-3' about='Thesaurus:DEFINITION' typeof='owl:Thing'>definition</span> key processes embryo                       suspected determined [5,6]. Another example given <br /> formation [1,2,3]. Importantly, processes evolutionarily                     clefts lip palate, genetic and <br /> conserved helped elucidate function human                           environmental factors involved [7,8]. Overall, represent a <br /> orthologous genes. This particularly beneficial                          substantial number congenital conditions genetics have <br /> these genes involved pathologies. In cancer, example,                    elucidated represent considerable <br /> many developmentally important genes reactivated                        clinical burden society. <br /> epithelial-to-mesenchymal transition precedes metastatic <br /> spread [4]. However, fully understand the <br />  <br />  <br /> PLOS ONE | www.plosone.org                                                         1                         September 2014 | Volume 9 | Issue 9 | e107674 <br />                                                                                                                          Alternative Isoforms Tks5 <br />  <br />  <br />    Tks5 adaptor protein identified novel Src                 Mice <br /> substrate [9]. Tks5 contains phox homology (PX) domain                         Sh3pxd2a mutant mice generated gene-trapping by <br /> located N-terminus 5 SH3 domains interspersed                 Lexicon Pharmaceuticals (The Woodlands, TX) (embryonic stem- <br /> several polyproline motifs 2 main Src phosphorylation sites               cell clone ID OST445753). Inactivation sh3pxd2a gene these <br /> (Y557 Y619) [10]. Tks5 demonstrated                        mice insertion trapping vector VICTR 37 between <br /> necessary formation function actin protease            exons 1 2 chromosome 19. After quarantine, mice were <br /> rich-structures podosomes invadopodia, collectively some-                 maintained standard pathogen-free conditions constant <br /> times known invadosomes [11]. Podosomes (in normal cells)              temperature humidity environment 12:12 light: dark <br /> invadopodia (in cancer cells) located ventral cellular             cycle ad libitum access food water Sanford- <br /> surface establish close contact extracellular             Burnham Medical Research Institute Animal Facility, La Jolla, <br /> matrix act degradation [12]. Src family kinases                California. The litters adults continuously monitored <br /> crucial podosome biology [13,14,15,16],               daytime Monday Friday, twice daily during <br /> suggested involved podosome initiation                    daytime Saturdays, Sundays, holidays signs poor <br /> disassembly [17]. In Src-transformed NIH3T3 cells, phosphory-                 health. When pups/adults showed signs poor health, as <br /> lation Tks5 events podosome formation               shakiness low activity decreased body temperature, <br /> [18], Tks5 associates Grb2 binds                  humanely euthanized. For neonates 7 days of <br /> phosphatidylinositol-3,4-bisphosphates forming                age: hypothermia (placing neonates plastic bags ice <br /> membrane nascent podosome PX domain                        10 minutes) followed decapitation razor blade. <br /> [12,18,19]. This binding facilitates direct indirect associa-          For animals older 7 days: CO2 inhalation mice <br /> tion Nck1, Nck2 N-WASP, followed intense                   stop breathing, followed cervical dislocation. These <br /> actin polymerization [10,18]. In cancer cells, Tks5 involved            methods approved Sanford-Burnham Medical <br /> invadopodia formation function [11] promotes reactive                 Research Institute Animal Care Use Committee following the <br /> oxygen species generation NADPH oxidase system,                     American Veterinary Medical Association guidelines the <br /> acting NADPH organizer binds p22phox [20,21].                      Euthanasia Animals (https://www.avma.org/KB/Policies/ <br />    In humans, TKS5 encoded SH3PXD2A gene, located                   Documents/euthanasia.pdf, sections S2.2.2.1, S2.2.2.3 S2.2.4.2.2, <br /> on chromosome 10, size 267 kb coding sequence                 http://grants.nih.gov/grants/olaw/Euthanasia2007.pdf). <br /> formed 15 exons. The closest homologue TKS5                         To assess disruption sh3pxd2a gene, embryonic <br /> protein TKS4, encoded SH3PXD2B gene. SH3PXD2A                          fibroblasts isolated E12.5 embryos genomic DNA <br /> and SH3PXD2B genes 47% sequence identity. They                    total protein extracted analyzed PCR and <br /> to arisen common precursor gene tunicate                immunoblotting, respectively. Mice carrying homozygous <br /> Ciona intestinalis sea urchin Strongylocentrotus purpur-              trapping <span id='am-319' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-320' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-321' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-322' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-323' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-324' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-325' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-326' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-327' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-328' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-329' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-330' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-331' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-332' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-333' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-334' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-335' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-336' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-337' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-338' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-339' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-340' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-341' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-342' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-343' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-344' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-345' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-346' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-347' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-348' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-349' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-350' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-351' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-352' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-353' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-354' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-355' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-356' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-357' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-358' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-359' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-360' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-361' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-362' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-363' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-364' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-365' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-366' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-367' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-368' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-369' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-370' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-371' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-372' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-373' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-374' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-375' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-376' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-377' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-378' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-379' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-380' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-381' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-382' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-383' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-384' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-385' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-386' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-387' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-388' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-389' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-390' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-391' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-392' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-393' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-394' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-395' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-396' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span>mutation</span> denominated Tks5trap/trap Tks5a/ <br /> atus present single gene encoding protein PX domain                Tks5long null mice, heterozygous mice appear Tks5+/trap <br /> followed 3 4 SH3 domains, respectively [22]. No                        wild types Tks5+/+. Sh3pxd2a mutant mice analyzed <br /> homologue gene flies worms, indicating                    C57BL/6Jx129/SvJ mixed background, provided by <br /> appeared late metazoan development. TKS4 PX domain                   Lexicon Pharmaceuticals, C57BL/6J pure background, <br /> followed 4 SH3 domains, domain identity                    obtained backcrossing mice 7 generations. <br /> higher 50% respect corresponding TKS5                        Strain purity assessed SNP analysis Murine Genetics <br /> domains. TKS4 Src substrate essential mature                Analysis Laboratory U.C. Davis, CA. The <span id='am-241' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-242' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-243' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-244' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-245' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-246' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-247' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-248' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-249' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-250' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-251' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-252' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-253' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-254' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-255' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-256' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-257' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-258' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-259' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-260' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-261' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-262' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-263' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-264' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-265' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-266' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-267' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-268' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-269' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-270' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-271' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-272' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-273' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-274' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-275' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-276' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-277' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-278' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-279' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-280' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-281' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-282' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-283' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-284' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-285' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-286' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-287' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-288' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-289' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-290' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-291' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-292' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-293' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-294' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-295' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-296' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-297' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-298' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-299' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-300' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-301' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-302' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-303' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-304' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-305' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-306' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-307' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-308' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-309' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-310' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-311' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-312' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-313' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-314' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-315' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-316' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-317' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-318' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span>phenotype</span> the <br /> podosome formation function [22]. Absence TKS4                      sh3pxd2a mutant mouse studied before. Homo- <br /> humans mice inactivating mutations gene deletion                zygous mutant mice phenotypic manifestations: dying <br />                                                                               24 hours life presence cleft palate; dying <br /> leads severe developmental defects craniofacial area, <br />                                                                               post day 1 life cleft palate; group reaching <br /> skeleton heart shortened lifespan, are <br />                                                                               adult life apparent phenotypic differences respect <br /> hallmarks Frank-Ter Haar syndrome [23]. Likewise, knock- <br />                                                                               normal littermates. We used 228 mice (n = 62 wild type, n = 113 <br /> down Tks5 zebrafish embryos causes abnormalities neural <br />                                                                               heterozygous, n = 53 homozygous mutant) total 30 litters <br /> crest cell-derived structures craniofacial zone <br />                                                                               C57BL/6Jx129/SvJ mixed background determine <br /> and pigment cells. Further analysis zebrafish embryos and <br />                                                                               accurately percentage mice three <br /> neural crest cells vitro indicated Src-activated Tks5 is <br />                                                                               phenotypic manifestations observed alleles sh3pxd2a <br /> necessary proper neural crest cell migration [24]. In light this <br />                                                                               mutated. Fewer mice yielded <span id='am-7' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-8' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-9' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-10' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-12' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-16' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-17' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-20' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-22' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-23' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-24' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-28' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-30' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-31' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-32' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-33' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-35' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-38' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-39' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-41' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-43' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-46' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-48' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-52' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-53' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-54' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-55' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-58' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-65' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-69' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-70' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-71' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-72' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-73' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-74' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-76' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-78' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-80' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-81' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-82' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-83' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-84' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span>survival</span> curve with <br /> finding, wondered role Tks5 mammalian <br />                                                                               significantly decreased survival probability homozygous <br /> development, choosing mouse model                     mutant mice allowed accurately <br /> genomic, physiological pathological similarities humans                determine percentage mutant mice phenotypic <br /> [25,26,27]. Here analysis mice bearing                  group, mice properly study phenotypes. <br /> inactivating gene-trap insertion intron 1 sh3pxd2a gene.            For C57BL/6J pure background analyzed 120 mice (n = 24 <br />                                                                               wild type, n = 61 heterozygous, n = 35 homozygous mutant) <span id='am-2' about='protege:FROM' typeof='owl:Thing'>from</span> <br /> Materials Methods                                                         total 15 litters. We analyzed quantity mice determine <br />                                                                               Tks5a mutation C57BL/6J pure background did not <br /> Ethics                                                                        allow survival mutant mice, contrast happens the <br />   This study approved Sanford-Burnham Medical                      C57BL/6Jx129/SvJ mixed background. Because outset we <br /> Research Institute Animal Care Use Committee (protocols                   na&#196;&#177;&#194;&#168;ve phenotypes observe, animal use <br /> 07-070 10-052; IACUC assurance number A3053/01),                      protocol included survival situation welfare mice <br /> performed accordance Institute Laboratory Animal               age. <br /> Research (NIH, Bethesda, MD) Guide care Use                       Double Tks4/Tks5 mutant heterozygous mice generated <br /> Laboratory Animals.                                                           crossing heterozygous sh3pxd2a mutant mice heterozy- <br />  <br />  <br /> PLOS ONE | www.plosone.org                                                2                      September 2014 | Volume 9 | Issue 9 | e107674 <br />                                                                                                                      Alternative Isoforms Tks5 <br />  <br />  <br /> gous sh3pxd2b mutant mice [23]. Blastocysts obtained              Synthesis System kit (Invitrogen). To quantify of <br /> described [28] 7 double heterozygous Tks4+/2, Tks5+/trap             mRNA Tks5a Tks5b murine tissues, following <br /> pregnant females crossed double heterozygous Tks4+/2,                primers designed: Tks5a sense 59-GGAGGACCCCTC- <br /> Tks5+/trap males.                                                         TAAACAC-39 (exon 1); antisense 59-ATCCTTTGCTTCG- <br />                                                                           GATCCTT-39 (exon 3); Tks5b sense 59- <br /> Reagents                                                                  TGTCTATCTGTTGTTGTTTCTTTTTC-39 (Tks5b unique <br />    Puromycin, neomycin, PP2, SU6656 MG132                   sequence exon 6b); antisense 59-GACCCAACCTTGCTCTT- <br /> EMD, blasticidin Invitrogen, doxycycline            CAG-39 (exon 9). Total actin expression used reference <br /> Sigma. Epoxomicin bortezomib gift Dr. Dieter              gene detected following primers: sense 59- <br /> Wolf, Sanford Burnham Medical Research Institute, La Jolla,               TGTTACCAACTGGGACGACA-39 (exon 3); antisense 59- <br /> California. SU11333 [29] synthesized A. Singh G. Roth           GGGGTGTTGAAGGTCTCAAA-39 (exon 4). All products were <br /> laboratory Sanford Burnham Medical Research Institute, Lake            sequenced assess specificity. Quantitative PCR were <br /> Nona, Florida. Saracatinib (AZD0530) gift Astra                performed MX3000 real-time PCR thermal cycler <br /> Zeneca [30].                                                              (Stratagene). Results analyzed plotted according the <br />                                                                           following equation: Result = [2 - (Ct Tks5 &#226;&#8364;&#8220; Ct total actin)] 610,000. <br />                                                                           Results multiplied 10,000 plotting purposes. <br /> Cell lines culture conditions <br />    Murine Embryonic Fibroblasts (MEFs) isolated from <br /> mouse embryos (E12.5) described [22]. NIH3T3 293T cells            Immunoprecipitation immunoblotting <br /> were obtained American Type Culture Collection.                     Cells lysed ice-cold lysis buffer containing 50 mM Tris <br /> NIH3T3 clone 7 mouse fibroblasts expressing active chicken c-Src          pH 7.6, 150 mM NaCl,1% TritonX-100, 10 mM NaF, 100 mM <br /> (SrcY527F) corresponding vector control cells           sodium orthovanadate protease inhibitors (Roche). Protein <br /> been previously described [9]. All cells maintained               concentration measured using BCA assay (Fisher) the <br /> DMEM (Mediatech) containing 10% FBS (Hyclone). To generate                total protein (between 0.5 1 mg) used to <br />                                                                           immunoprecipitate Tks5. Tks5 antibodies used study <br /> Src-transformed MEFs, cells infected retroviral pBabe <br />                                                                           include: 1) in-house polyclonal Tks5 antibody (named 1737), <br /> construct encoding active human c-Src (Y530F) selected with <br />                                                                           raised fourth SH3 domain Tks5 (used for <br /> 10 mg/ml puromycin (EMD). To generate lines expressing <br />                                                                           immunoprecipitation immunoblotting), 2) in-house poly- <br /> Tks5b, cells infected Tks5b-expressing <br />                                                                           clonal antibody raised PX domain (named 7768), used <br /> lentiviral pCDH constructs selected puromycin or <br />                                                                           immunoblotting, c) in-house monoclonal Tks5 antibody <br /> neomycin. To generate Src-transformed cells expressing Tks5short, <br />                                                                           (named 6G1) raised fourth SH3 domain Tks5 (used <br /> cells infected lentiviral stocks generated pCW22- <br />                                                                           immunoprecipitation), 4) commercial polyclonal Tks5 <br /> Tks5short construct obtained Dr. Tyler Jacks [31]. Cells were <br />                                                                           antibody raised fourth SH3 domain (Millipore catalog <br /> selected 5 mg/ml blasticidin. To induce expression of <br />                                                                           number 09-268), used immunoblotting. Complexes were <br /> Tks5short, cells treated 50 nM doxycycline 24 h. <br />                                                                           captured protein A-conjugated beads (EMD) 2 h at <br />                                                                           4uC. After electrophoresis electrotransfer, membranes were <br /> 59 Rapid Amplification cDNA ends (RACE)                                blotted 1737 anti-pTyr antibody (4G10, Millipore). <br />    Identification new transcription initiation site         Secondary antibodies conjugated Alexa Fluor 680 from <br /> sh3pxd2a gene 59 RACE (SMART RACE cDNA                        Life Sciences Technology, IR800 antibodies from <br /> Amplification kit; Clontech) analysis Src-transformed non-         Rockland. Bands visualized quantified using Odyssey <br /> transformed NIH3T3 cells total RNA, according manufactur-              infrared imaging (LI-COR). <br /> er&#226;&#8364;&#8482;s instructions, following exceptions: antisense primers <br /> were located exon 14 (59-GCCTTCTGTCCGCCTCGAA-39)                       Phosphatase treatment <br /> or exon 15 (59-CCTCGGCCTCCTTAGGCTTG-39),                             Cell lysates immunoprecipitated Tks5 using 6G1 <br /> PCR amplification step performed using sense primer (59-            antibody lambda protein phosphatase treatment (Cell <br /> AGCCCCTGCCAGTCCTAACC-39) located upstream                          Signaling Technologies) performed immunopre- <br /> putative alternative ATG intron V. The resulting products              cipitation wash. Phosphatase added according the <br /> were cloned pCR-XL-TOPO (Invitrogen) vector, digested            manufacturer&#226;&#8364;&#8482;s instructions presence absence of <br /> with EcoRI sequenced.                                                 100 mM sodium orthovanadate. Samples boiled sample <br />                                                                           buffer separated electrophoresis. <br /> Cloning <br />    To generate lentiviral vector construct encoding mouse               Statistics <br /> Tks5b, XhoI/BlpI fragment excised 59RACE                     Data analyzed Graph Pad Prism 5 software. Mice <br /> product cloned pCR-XL-TOPO vector cloned frame                survival data analyzed using Mantel-Cox Gehan- <br /> into XhoI/BlpI-digested pCDNA3 vector expressing <span id='am-5' about='xsp:length' typeof='owl:Thing'>length</span>            Breslow-Wilcoxon statistical tests. For experiments results <br /> Tks5 (not containing exons 7 10). A XhoI/XbaI fragment            represented mean value standard error three <br /> the resulting construct cloned XhoI/XbaI-digested         replicates. Statistical significance calculated using the <br /> pCDH-MCS-EF1-puro lentiviral vector (System Biosciences).                 Student&#226;&#8364;&#8482;s t test. <br />  <br /> RNA isolation qPCR analysis                                           Results <br />   Total RNA cells tissues purified using TRIzol <br /> reagent (Invitrogen) according manufacturer&#226;&#8364;&#8482;s instructions. We         Homozygous mutation sh3pxd2a mice causes cleft <br /> used TissueRuptor (Qiagen) homogenizer tissue disruption.             palate <br /> 1 mg RNA treated Deoxyribonuclease I (Invitrogen) prior            In order study function Tks5 mammalian <br /> to cDNA generation using SuperScript III first-Strand                 development, obtained sh3pxd2a gene-trapped mice from <br />  <br />  <br /> PLOS ONE | www.plosone.org                                            3                      September 2014 | Volume 9 | Issue 9 | e107674 <br />                                                                                                                         Alternative Isoforms Tks5 <br />  <br />  <br /> Lexicon Pharmaceuticals. The trapping cassette (vector                      11 Tks4-/-; Tks5trap/trap double null blastocysts total 116 <br /> VICTR37) inserted intron 1 sh3pxd2a gene                   blastocysts analyzed, indicating absence Tks proteins does <br /> chromosome 19 (Figure 1 A). Sh3pxd2a homozygous mutant mice                 cause embryonic lethality implantation. Together, these <br /> (Tks5trap/trap hereafter) born Mendelian ratios (Figure 1B)         data demonstrate importance Tks5 correct mammalian <br /> and reduced survival respect wild-type                      development post-implantation, suggests intricate regula- <br /> heterozygous littermates (Figure 1 C). On C57BL/6Jx129/SvJ                tion Tks proteins implantation and/or embryonic <br /> mixed genetic background, 50 percent Tks5trap/trap mice              development, distinct roles developmental stages and <br /> died 24 hours life, 30 percent died day 1       compensatory/redundant functions others. <br /> of life time weaning, remaining 20 percent survived <br /> throughout adulthood apparent phenotypic defects.                   Different isoforms Tks5 generated alternative <br /> Tks5trap/trap pups dead 24 hours life did           transcription sh3pxd2a gene <br /> have milk stomachs, analyzed                     To analyze degree protein loss achieved trapping <br /> presented complete cleft secondary palate (Figure 1 D).              cassette, isolated murine embryonic fibroblasts (MEFs) from <br /> Gross analysis dead pups age #24 hours showed              E12.5 embryos Tks5+/trap intercrossings analyzed Tks5 <br /> Tks5trap/trap neonates sporadic bifid xiphisternum (data            protein expression immunoblot (Figure 1 F). Tks5 protein <br /> shown), obvious developmental defects found.              detection immunoblot characterized presence <br /> Tks5trap/trap pups dying day 1 life weaning time             triplet set bands ranging 130&#226;&#8364;&#8220;150 kDa, exact <br /> were able eat presented cleft palate,               origin characteristics unknown [9]. Surprisingly, <br /> eventually failed thrive died. To elucidate              presence trapping cassette affected only <br /> phenotypic diversity Tks5trap/trap mice irregular         expression band Tks5 triplet, was <br /> efficiency trapping cassette genetic background                diminished heterozygous MEFs absent homozygous <br /> impurity, sh3pxd2a mice backcrossed C57BL/6J                  MEFs. This finding hypothesize presence an <br /> pure background. Tks5trap/trap mice pure C57BL/6J                      internal alternative promoter downstream intron I would <br /> background born Mendelian ratios (Figure 1 B).                 generate shorter forms Tks5 unaffected action the <br /> However, presence complete cleft secondary palate                 trapping cassette. Supporting hypothesis, two <br /> associated neonatal death Tks5trap/trap mice increased           human EST sequences (GenBank accession numbers DC332430 <br /> 90 percent. The 10 percent remaining died shortly             BP219917) homology human SH3PXD2A gene <br /> unknown causes, presence cleft palate (Figure 1 C).          coding sequence lack exons 1 5, ones <br /> Therefore, strain purity affect phenotypic manifestations        encoding PX domain (Figure 2 A) [9]. Instead, 29- <br /> sh3pxd2a <span id='am-85' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-86' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-87' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-88' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-89' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-90' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-91' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-92' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-93' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-94' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-95' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-98' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-99' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-100' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-101' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-102' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-103' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-104' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-105' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-106' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-107' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-108' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-109' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-110' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-111' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-112' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-113' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-114' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-115' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-116' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-117' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-118' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-119' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-120' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-125' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-126' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-127' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-128' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-130' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-131' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-132' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-133' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-134' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-135' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-136' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-137' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-139' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-142' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-144' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-145' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-147' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-150' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-151' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-152' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-153' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-154' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-155' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-156' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-157' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-158' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-159' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-160' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-161' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-162' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span>gene mutation</span>. We did gross phenotypic                <span id='am-475' about='xsp:base' typeof='owl:Thing'>base</span> sequence upstream beginning exon 6 starts an <br /> differences heterozygous wild-type mice,             in-frame ATG (Figure 2 B). Also, DC332430 contains exon 7 but <br /> Tks5trap/trap male female mice, mixed           lacks exon 10, BP219917 lacks exon 7 contains exon 10: <br /> pure C57BL/6J background.                                                   exons described previously alternatively <br />    We previously cloned characterized Tks4, related              spliced [9]. Alignment human EST sequences mouse <br /> adaptor protein presents highest homology Tks5 [22].            sh3pxd2a gene sequence revealed high homology the <br /> Both Tks4 Tks5 necessary mature podosome                        existence in-frame ATG (Figure 2 B). To ascertain if <br /> formation [11] distinct functions, Tks4 null            conserved ATG indicating new alternative translational <br /> Src-transformed murine embryonic fibroblasts (MEFs) transfected             start site sh3pxd2a gene, performed 59-RACE cDNA <br /> with human TKS5 protein recover ability form podosomes               Src-transformed non Src-transformed NIH3T3 mouse <br /> but fail degrade gelatin, transfection human             fibroblasts, forward primer located upstream putative <br /> TKS4 rescues podosome formation function [22]. Tks4                start site (Figure 2 B) reverse primers located exon 14 <br /> null mice born Mendelian ratios present severe                   15. We obtained clones Src-transformed NIH3T3 <br /> developmental anomalies craniofacial bones, skeleton, heart          cells clone non Src-transformed NIH3T3 cells which <br /> and eyes compromise long-term survival [23]. To             encoded sequence, starting alternative ATG on <br /> out Tks5 Tks4 interact mammalian development,              intron V lacking exon 7 containing exon 10 (Figure 2 C). <br /> created mice doubly heterozygous Tks4 Tks5 crossing              This finding suggests existence alternative promoter in <br /> sh3pxd2a sh3pxd2b mutant mouse lines (both C57BL/                  intron V encode distinct isoform Tks5 lacking PX <br /> 6Jx129/SvJ mixed background), used intercross                   domain, contain exons 1 5. The new isoform <br /> matings analyze offspring birth. Figure 1E shows              coding sequence starts 29 bp upstream exon 6 includes as <br /> number mice born expected genotype. No Tks4-/-;                 alternative exon 58 bp long named exon <br /> Tks5trap/trap double null mice born total 511 mice             6b (Figure 2 C 2 D). <br /> from 67 litters analyzed, suggesting overlapping and/or                     The existence different alternative transcriptional start sites in <br /> compensatory function Tks4 Tks5 development.                  sh3pxd2a gene explain detection bands <br /> The numbers mice homozygous mutant gene                      immunoblotting Tks5, highest band (150 kDa) <br /> heterozygous (Tks4-/-; Tks5+/trap Tks4+/2;                corresponding protein PX domain, lower <br /> Tks5trap/trap) expected Mendelian ratios well,            ones (140 130 kDa) lacking PX domain. To test this <br /> supporting hypothesis.                                                 possibility, generated rabbit polyclonal antibody the <br />    Recently, shown trophoblasts form                   PX domain Tks5, recognize PX-lacking <br /> podosomes [32], suggests role podosome regulators           Tks5 isoform. We tested specificity Tks5 PX antibody on <br /> Tks4 and/or Tks5 trophoblast function                   293T cells transfected constructs encoding full-length Tks5 or <br /> implantation. To investigate absence Tks4 Tks5           Tks5 mutant lacking PX domain (DPX Tks5) (Figure 3 A). <br /> proteins caused lethality implantation,                  We immunoprecipitated 293T lysates 1737 antibody <br /> genotyped E3.5 pre-implantation blastocysts double hetero-             (raised 4th SH domain Tks5), sequentially <br /> zygous (Tks4+/2; Tks5+/trap) mice intercross matings. We detected           immunoblotted membrane Tks5 PX 1737 <br />  <br />  <br /> PLOS ONE | www.plosone.org                                              4                       September 2014 | Volume 9 | Issue 9 | e107674 <br />                                                                                                                              Alternative Isoforms Tks5 <br />  <br />  <br />  <br />  <br /> Figure 1. The sh2pxd2a gene essential correct mammalian development. (A) Map sh2pxd2a gene location trapping <br /> cassette used generate sh2pxd2a mutant mice. Exons indicated black boxes order number top. Trapping cassette inserted in <br /> intron 1. (B) Absolute numbers percentages (in parentheses) sh3pxd2a mice (Tks5) born heterozygous intercrosses C57BL/6Jx129/SvJ <br /> mixed strain background C57BL/6J pure strain. (C) Survival curves Tks5 mice C57BL/6Jx129/SvJ mixed background (left) pure C57BL/6J <br /> background (right). Wild type mice indicated blue, Tks5+/trap mice green Tks5trap/trap mice red. Statistical analysis conducted using <br /> both Mantel-Cox Gehan-Breslow-Wilcoxon tests, p values 0.0001 cases. (D) Representative photographs showing the <br /> palates Tks5 wild-type (+/+), Tks5 heterozygous mutant (+/trap) Tks5 homozygous mutant (trap/trap) neonates. Asterisk denotes nasal <br /> septum. (E) Offspring genotype numbers born Tks4+/2, Tks5+/trap double heterozygous mice intercrosses. Numbers outside parentheses show <br /> the observed number mice born indicated genotype, numbers parentheses correspond expected number mice <br /> according Mendelian laws. (F) Immunoblot Tks5 protein extracts MEFs obtained Tks5 wild type, heterozygous (+/trap) and <br /> homozygous mutant (trap/trap) E12.5 mouse embryos. Tks5 immunoprecipitated immunoblotted polyclonal Tks5 antibody raised <br /> against 4th SH3 domain (1737). <br /> doi:10.1371/journal.pone.0107674.g001 <br />  <br />  <br />  <br />  <br /> antibodies. As expected, PX domain antibody detected                   gives rise different mRNA transcripts translated into <br /> full length Tks5 Tks5 construct lacking PX domain               Tks5 isoforms: PX-containing Tks5a/Tks5long isoform <br /> (Figure 3 A, left panel). To ascertain triplet                   site initiation transcription upstream exon 1, the <br /> observe NIH3T3 mouse fibroblasts corresponds PX-                          PX-lacking isoforms Tks5short novel Tks5b, having a <br /> containing PX-lacking Tks5 isoforms, immunoprecipitated                  site initiation transcription downstream exon 5. <br /> Src-transformed parental NIH3T3 lysates 1737 and <br /> sequentially immunoblotted membrane Tks5                      Tks5a Tks5b mRNA tissue expression analysis reveals <br /> PX 1737 antibodies (Figure 3 B). In agreement                      isoform cross-regulation normal physiological <br /> hypothesis, observed upper band (150 kDa) of <br />                                                                                 conditions <br /> both cell lines recognized Tks5 PX antibody, whereas <br />                                                                                    Next, analyzed expression Tks5a/Tks5long Tks5b <br /> all Tks5 bands recognized 1737 antibody. These <br />                                                                                 mRNA different murine organs RT-qPCR (Figure 4). To <br /> results confirm 150 kDa band Tks5 triplet <br />                                                                                 specifically detect mRNA Tks5a isoform designed <br /> corresponds PX domain-containing Tks5 isoform the <br />                                                                                 qPCR primers aligning exons 1 3, encode of <br /> lowest bands 140 130 kDa Tks5 isoforms lacking PX <br />                                                                                 PX domain. To specifically detect Tks5b isoform, we <br /> domain. We named Tks5a PX domain-containing isoform, <br />                                                                                 designed primers located newly discovered unique sequence <br /> and Tks5b isoform coding sequence starting exon 6b <br /> and lacking PX domain (Figure 2 D). Recently, additional                 exon 6b exon 9. We normalized results the <br /> isoform mouse Tks5, named Tks5short, described Li                total actin mRNA expression organ analyzed. We detected <br /> et al. [31]. Tks5short contains exons 8 15 preceded unique              expression isoforms organs analyzed (lung, liver, <br /> sequence encoded intron VII (Figure 2 D). Li et al.              heart, skeletal muscle, kidney, spleen white adipose tissue) and <br /> well PX-domain containing Tks5 isoform (that named                     MEFs (Figure 4 A B), expression Tks5a/ <br /> Tks5long), corresponds Tks5a isoform described here.               Tks5long mRNA isoform markedly higher tissues <br /> Collectively, data strongly suggest sh3pxd2a gene                compared Tks5b isoform, ranging 400-fold in <br />  <br />  <br /> PLOS ONE | www.plosone.org                                                  5                       September 2014 | Volume 9 | Issue 9 | e107674 <br />                                                                                                                   Alternative Isoforms Tks5 <br />  <br />  <br />  <br />  <br /> Figure 2. The sh3pxd2a gene encodes different isoforms Tks5. (A) Alignment human ESTs DC332430 (blue) BP219917 (red) with <br /> the human SH3PXD2A gene (bottom). SH3PXD2A exons represented boxes lines exon number bottom. Exons included in <br /> each EST indicated colored continuous line corresponding exon framed dashed black lines. Dashed colored lines <br />  <br />  <br />  <br /> PLOS ONE | www.plosone.org                                           6                     September 2014 | Volume 9 | Issue 9 | e107674 <br />                                                                                                                              Alternative Isoforms Tks5 <br />  <br />  <br />  <br /> indicate splicing. (B) Sequence 59 ends ESTs BP219917 DC332430 end exon 6 alignment sequences human <br /> SH3PXD2A mouse sh3pxd2a genes. Base coincidence indicated black vertical lines. Exon 6 sequences shown inside light green <br /> filled box, blue line indicates binding site 59 RACE primer, red ATG bases alternative initiation translation codon site exon 6b is <br /> denoted dark green-lined box. (C) Predicted amino acid sequence new Tks5b isoform. Residues encoded exon 6b inside dark <br /> green-lined box, ones encoded exon 6 shown light-green background. Underlined residues indicate encoded exon 7 10, <br /> which present protein alternative splicing. (D) Schematic representation 3 transcripts arise from <br /> alternative transcription mouse sh3pxd2a gene correspondence different protein domains. Exons represented boxes <br /> with corresponding number inside, exon 6 represented light-green box exon 6b dark-green box. Exons 7 10 represented <br /> by gray boxes subject alternative splicing transcript. Black lines arrows the <br /> correspondence exons protein domains. Tks5short Tks5long isoforms described recently Li et al. [31], Tks5long is <br /> identical Tks5a described here. <br /> doi:10.1371/journal.pone.0107674.g002 <br />  <br /> liver spleen 27-fold kidney 8-fold MEFs. Heart                 (passage 1). First, unequivocally detect expression of <br /> was organ highest expression isoforms                      Tks5b mRNA tissues MEFs Tks5a null mice, <br /> compared total actin expression. Lung liver high              while, expected, detected extremely low amounts no <br /> expression Tks5a/Tks5long isoform. Next, wondered                  expression Tks5a/Tks5long mRNA (data shown). Then, we <br /> expression Tks5a/Tks5long affect Tks5b mRNA                        compared Tks5b mRNA expression wild type mice <br /> expression vice versa. To assess this, took advantage             Tks5a/Tks5long mutant littermates. We observed the <br /> fact 20% Tks5a/Tks5long null mice C57BL/                     relative abundance Tks5b lung, skeletal muscle, kidney, white <br /> 6Jx129/SvJ mixed background survive adulthood (Figure 1                    adipose tissue MEFs wild-type mice just slightly elevated <br /> C), compared expression Tks5b mRNA isoform                    respect Tks5a/Tks5long mutant mice (1-fold 3-fold). <br /> organs 3 mice wild-type littermates (5&#226;&#8364;&#8220;8              However, liver spleen wild-type mice 10-fold and <br /> months old) (Figure 4 C). We compared Tks5b mRNA                    5-fold higher expression Tks5b respect Tks5a/Tks5long <br /> expression Tks5a/Tks5long mutant wild type MEFs                          mutant mice. In contrast, hearts wild-type mice 50% <br />                                                                                 decreased expression Tks5b mRNA comparison null mice. <br />                                                                                 These data indicate Tks5a/Tks5long Tks5b isoforms <br />                                                                                 expressed transcript level adult organs during <br />                                                                                 normal physiological conditions, suggest differential <br />                                                                                 expression Tks5a/Tks5long Tks5b isoforms organ- <br />                                                                                 dependent manner. Furthermore, comparison Tks5b mRNA <br />                                                                                 expression wild-type mice littermates lacking Tks5a/ <br />                                                                                 Tks5long suggest cross-regulation mRNA abundance <br />                                                                                 isoforms. <br />  <br />                                                                                 Protein expression endogenous non PX- <br />                                                                                 containing Tks5 isoforms regulated activity of <br />                                                                                 Src <br />                                                                                    Transformation NIH3T3 mouse fibroblasts active Src <br />                                                                                 induced increase levels highest molecular weight <br />                                                                                 Tks5 band (150 KDa), concomitant disappearance the <br />                                                                                 Tks5 bands 140 130 kDa, correspond PX- <br />                                                                                 lacking Tks5 forms (Figures 3 B, 5 A [11]). This effect not <br />                                                                                 cell-line specific, transformation primary MEFs active <br />                                                                                 Src effect (Figure 5 C compare lanes 1 5). <br />                                                                                 Furthermore, Src kinase activity necessary mediate the <br />                                                                                 switch higher lower molecular weight bands, as <br />                                                                                 evidenced treatment pharmacological inhibitors of <br />                                                                                 Src-family kinases SU6656, PP2 AZD0530 (saracatinib) in <br />                                                                                 Src-transformed cells (Figure 5 A&#226;&#8364;&#8220;D). Interestingly, treatment with <br />                                                                                 Src-family kinase inhibitors significantly increased expression <br />                                                                                 PX-lacking Tks5 isoforms Src-transformed NIH3T3 <br />                                                                                 (Figure 5 A, asterisks) MEFs (Figure 5 C, asterisks), as <br />                                                                                 quantified Figure 5B D. We wondered effect <br />                                                                                 differences transcription PX-containing <br /> Figure 3. Immunoblot detection PX-lacking containing <br /> Tks5 isoforms. (A) Lysates 293T cells transfected constructs <br />                                                                                 PX-lacking Tks5 isoforms control Src-trans- <br /> expressing full-length Tks5 protein (Tks5) Tks5 protein lacking PX       formed cells. To address this, analyzed effect Src <br /> domain (DPX Tks5) immunoprecipitated polyclonal Tks5                transformation mRNA expression different Tks5 <br /> antibody raised 4th SH3 domain (1737) sequentially              isoforms RT-PCR. We used Tks5a/Tks5long Tks5b <br /> immunoblotted Tks5 PX antibody (left panel) 1737                  specific primers (Figure 4), primers specific the <br /> antibody (right panel). (B) Lysates parental Src-transformed            Tks5short form obtained Dr. Tyler Jacks [31], perform <br /> NIH3T3 cells immunoprecipitated polyclonal Tks5 antibody <br /> raised 4th SH3 domain (1737) sequentially immuno- <br />                                                                                 PCR. As expected, primary MEFs derived Tks5trap/trap <br /> blotted Tks5 PX antibody (left panel) 1737 antibody (right        mice, mRNA Tks5a/Tks5long significantly <br /> panel). Numbers left indicate kDa.                                       decreased, mRNA expression non <br /> doi:10.1371/journal.pone.0107674.g003                                           PX-containing Tks5 isoforms (Tks5b Tks5short) un- <br />  <br />  <br /> PLOS ONE | www.plosone.org                                                  7                       September 2014 | Volume 9 | Issue 9 | e107674 <br />                                                                                                                            Alternative Isoforms Tks5 <br />  <br />  <br />                                                                                  transformed counterparts. No significant changes mRNA <br />                                                                                  levels Tks5 isoforms observed control <br />                                                                                  Src-transformed cells (Figure 5 E, right panel), indicating that <br />                                                                                  changes previously observed protein expression the <br />                                                                                  Tks5 isoforms Src transformation likely post- <br />                                                                                  translational modifications. <br />  <br />                                                                                  Tks5b protein expression regulated Src activity and <br />                                                                                  proteasome degradation pathway <br />                                                                                     To verify 59-RACE product (Figure 2 C) encodes a <br />                                                                                  Tks5 protein expected molecular size, used 59-RACE <br />                                                                                  product generate lentiviral-based expression construct for <br />                                                                                  Tks5b. We generated lentiviruses infected parental Src- <br />                                                                                  transformed NIH3T3 mouse fibroblasts selected infected <br />                                                                                  cells puromycin generate stable cell lines. Protein extracts <br />                                                                                  resulting cell lines analyzed immunoprecipitation <br />                                                                                  Tks5 6G1 antibody followed immunoblotting a <br />                                                                                  polyclonal commercial Tks5 antibody. Expression Tks5b in <br />                                                                                  NIH3T3 cells rendered single band 130 kDa, whereas <br />                                                                                  expression Src-transformed mouse fibroblasts rendered two <br />                                                                                  bands 140 130 kDa exhibited identical migration <br />                                                                                  patterns Tks5 lower molecular weight bands untrans- <br />                                                                                  formed mouse fibroblasts (Figure 6 A). This contrast with <br />                                                                                  overexpression Tks5short isoform, rendered a <br />                                                                                  single &#226;&#8364;&#732;&#226;&#8364;&#732;middle&#226;&#8364;&#8482;&#226;&#8364;&#8482; band 140 kDa (Figure 6 B) Src-transformed <br />                                                                                  NIH3T3 cells. These results confirmed 59-RACE product <br />                                                                                  Tks5b encodes Tks5 protein expected molecular <br />                                                                                  size. <br />                                                                                     We consistently observed independent infections the <br />                                                                                  expression Tks5b lower Src-transformed fibroblasts than <br />                                                                                  parental cells (Figure 6 A). This suggested Tks5b be <br />                                                                                  unstable presence active Src, fashion similar the <br />                                                                                  endogenous non-PX containing Tks5 bands (Figure 5 A, C). To <br />                                                                                  address question, treated control Tks5b expressing <br />                                                                                  Src-transformed cells Src family kinase inhibitors SU6656 <br />                                                                                  derivative SU11333, analyzed effect the <br />                                                                                  expression Tks5. Consistent effect inhibiting Src <br />                                                                                  activity protein expression endogenous non-PX <br />                                                                                  containing Tks5, inhibition Src Tks5b-expressing Src- <br />                                                                                  transformed fibroblasts increased the middle and <br />                                                                                  lower Tks5 bands (Figure 6 C). These results confirmed the <br />                                                                                  Tks5b protein unstable cells elevated Src kinase activity. <br />                                                                                     Tks5 identified direct Src substrate [9]. Two main <br />                                                                                  tyrosine residues Tks5 (Tyr557 Tyr619) targets Src <br />                                                                                  kinase activity [9,10]. These tyrosine residues present both <br />                                                                                  Tks5a/Tks5long Tks5b. To analyze Tks5b tyrosine- <br /> Figure 4. Tks5a/Tks5long Tks5b mRNA expression adult <br /> mice organs normal physiological conditions. Total RNA                    phosphorylated Src-transformed NIH3T3 cells, subjected <br /> was extracted organs 3 wild type mice aged 5&#226;&#8364;&#8220;8 months (A&#226;&#8364;&#8220;              cell extracts parental, vector control Tks5b- <br /> C) 3 Tks5a/Tks5long null littermates (C), retrotranscribed          expressing Src-transformed NIH3T3 fibroblasts treatment with <br /> cDNA Tks5a/Tks5long Tks5b specific mRNA detection qPCR.               lambda phosphatase presence absence phosphatase <br /> (A) Tks5a/Tks5long (B) Tks5b mRNA detection wild-type murine              inhibitor sodium orthovanadate (Figure 6 D). After de-phosphor- <br /> organs MEFs. The Tks5a/Tks5long Tks5b corrected <br />                                                                                  ylation, samples separated electrophoresis, transferred and <br /> by expression total actin mRNA sample (see <br /> materials methods). Columns average 3 different wild             sequentially immunoblotted anti-phosphotyrosine anti- <br /> type mice 2 different wild type MEF cell lines. (C) Tks5b mRNA               body Tks5 antibody. In parental vector control <br /> expression ratio wild type (WT) Tks5a/Tks5long null organs           cells, phosphatase treatment absence sodium orthovana- <br /> and MEFs. Columns average 3 ratios corresponding 3                date led undetectable tyrosine phosphorylation Tks5a/ <br /> pairs wt-trap littermates, MEFs average 5 ratios             Tks5long form, appearance smaller Tks5 form <br /> corresponding 2 null lines: 1 wt line obtained litter, 3 <br />                                                                                  mobility compatible middle 140 kDa <br /> null lines: 1 wt obtained second litter. WAT: white adipose tissue. <br /> doi:10.1371/journal.pone.0107674.g004                                            band (Figure 6 D). This consistent appearance <br />                                                                                  non-PX containing forms Tks5 Src-transformed cells <br />                                                                                  treatment Src kinase inhibitors (Figure 5 A, C). <br /> changed (Figure 5 E, left panel). Next, performed RT-PCR <br />                                                                                  Interestingly, small exogenous Tks5b present in <br /> analysis detect mRNA different Tks5 isoforms in <br />                                                                                  Src-transformed extracts showed high levels tyrosine phosphor- <br /> NIH3T3 fibroblasts primary MEFs Src- <br />                                                                                  ylation, inhibition phosphorylation phosphatase <br />  <br />  <br /> PLOS ONE | www.plosone.org                                                   8                      September 2014 | Volume 9 | Issue 9 | e107674 <br />                                                                                                                             Alternative Isoforms Tks5 <br />  <br />  <br />  <br />  <br /> Figure 5. Protein expression endogenous non PX-containing Tks5 isoforms regulated activity Src. (A) Tks5 <br /> immunoblotting extracts Src-transformed NIH3T3 cells control counterparts treatment 5 mM concentration the <br /> indicated Src family kinase inhibitors 24 h. Numbers left indicate kDa. Asterisks indicate Tks5 middle low bands corresponding non- <br /> PX containing Tks5 isoforms. (B) Quantification independent experiments using densitometric analysis 140 130 kDa bands <br /> combined. Average pixel intensity (arbitrary units) standard deviations shown. (*) p,0.0001; (**) p,0.0005 using Student&#226;&#8364;&#8482;s t test. (C) Tks5 <br /> immunoblotting extracts Src-transformed MEFs control counterparts treatment 5 mM concentration indicated Src <br /> family kinase inhibitors 24 h. Numbers left indicate kDa. Asterisks indicate Tks5 middle low bands corresponding non-PX containing <br /> Tks5 isoforms. (D) Quantification independent experiments using densitometric analysis 140 130 kDa bands combined. Average <br /> pixel intensity (arbitrary units) standard deviations shown. (*) p,0.0001; (**) p,0.01; (***) p,0.001 using Student&#226;&#8364;&#8482;s t test. (E) RT-PCR analysis <br /> for indicated Tks5 isoforms. Left column: Analysis MEFs wild type Tks5a/Tks5long null mice. Right column: Analysis control Src- <br /> transformed cells (MEFs NIH3T3) indicated. <br /> doi:10.1371/journal.pone.0107674.g005 <br />  <br /> treatment absence sodium orthovanadate led                    findings suggest Tks5b protein stability tightly <br /> stabilization overexpressed Tks5b (Figure 6 D). Taken                   regulated proteasome tyrosine phosphorylation <br /> together, results indicate tyrosine phosphorylation              Src family kinases and/or kinases target Tks5b to <br /> Tks5b regulates protein stability.                                         degradation proteasome conditions elevated Src <br />    Since protein tyrosine phosphorylation target proteins              activity. <br /> degradation proteasome pathway, treated Src- <br /> transformed cells expressing exogenous Tks5b protea-                  Discussion <br /> some inhibitor MG132. Src-transformed cells sensitive <br /> to effects inhibitor died hours                   In study, main findings: essentiality of <br /> treatment, making results difficult interpret. To overcome              PX domain-containing Tks5 isoform proper mammalian <br />                                                                                development, existence additional isoform Tks5, <br /> this issue, overexpressed Tks5b 293T cells analyzed the <br />                                                                                named Tks5b, lacks PX domain originated by <br /> effect different proteasome inhibitors (MG132, epoxomi- <br />                                                                                alternative transcription. <br /> cin bortezomib) expression Tks5 isoform. <br />                                                                                   First, disruption mouse sh3pxd2a <br /> Accumulation overexpressed Tks5b observed upon <br />                                                                                gene insertion gene-trap cassette exons 1 <br /> treatment inhibitors (Figure 7 A, B). Taken together, <br />                                                                                2 led absence Tks5a/Tks5long protein isoform, <br />  <br />  <br /> PLOS ONE | www.plosone.org                                                 9                        September 2014 | Volume 9 | Issue 9 | e107674 <br />                                                                                                                               Alternative Isoforms Tks5 <br />  <br />  <br />  <br />  <br />                                                                                  Figure 7. Tks5b protein abundance regulated the <br />                                                                                  proteasome degradation pathway. (A) Tks5 immunoblotting on <br />                                                                                  extracts 293T cells expressing vector Tks5b upon <br />                                                                                  treatment proteasome inhibitors MG132 (5 mM), epoxomicin <br />                                                                                  (50 nM) bortezomib (50 nM) 16 h. An extract NIH3T3 cells was <br />                                                                                  run control mobility non-PX containing Tks5 isoforms <br />                                                                                  (asterisks). (B) Quantification independent experiments using <br />                                                                                  densitometric analysis 130 kDa band. Average pixel intensity <br />                                                                                  (arbitrary units) standard deviations shown. (*) p,0.001; (**) p, <br />                                                                                  0.0005; (***) p,0.005 using Student&#226;&#8364;&#8482;s t test. <br />                                                                                  doi:10.1371/journal.pone.0107674.g007 <br />  <br />                                                                                  [7,33,34,35]. Cleft palate appear associated defects <br /> Figure 6. Tks5b protein expression regulated Src activity. <br />                                                                                  syndrome, usually genetic origin Mendelian <br /> (A) Tks5 immunoblotting extracts Src-transformed NIH3T3 cells <br /> and control counterparts expressing vector Tks5b.                 inheritance, non-syndromic isolated trait both <br /> Number left indicate kDa. Asterisks indicate Tks5 middle                  genetic environmental factors contribute create complex <br /> (140 kDa) low (130 kDa) bands. (B) Tks5 immunoblotting                    etiology difficult study [7,8,33,36]. We identified presence of <br /> extracts Src-transformed NIH3T3 cells expressing inducible               cleft palate mainly isolated phenotype Tks5a/Tks5long <br /> Tks5short isoform induction Doxycycline 24 h.           null mice, exception sporadic bifid xiphoid cartilage of <br /> Number left indicates kDa. Asterisks indicate Tks5 middle <br /> (140 kDa). (C) Tks5 immunoblotting extracts Src-transformed <br />                                                                                  sternum. However, predict absence TKS5a/ <br /> NIH3T3 cells expressing vector Tks5b treatment              TKS5long contribute etiology syndromic non- <br /> 5 mM concentration indicated Src family kinase inhibitors 16h.        syndromic cleft palate humans, mutation sh3pxd2a <br /> Number left indicates kDa. Asterisks indicate Tks5 middle             gene inherited Mendelian fashion syndromes are. <br /> low bands corresponding non-PX containing Tks5 isoforms. (D) Tks5             On basis, possible TKS5a/TKS5long mutation <br /> immunoblotting extracts Src-transformed NIH3T3 cells                     origin 752 diseases Mendelian inheritance <br /> untreated expressing vector Tks5b treatment with <br /> lambda protein phosphatase presence absence sodium                  orphan cause described OMIM. In mammals, the <br /> orthovanadate. Asterisk indicate Tks5 middle (140 kDa) band.                     secondary palate formation takes place early development <br /> doi:10.1371/journal.pone.0107674.g006                                            (seventh week humans E11.5 mice) palatal <br />                                                                                  shelves emerge maxillary process [37]. The palatal <br /> which associated complete cleft secondary palate                 shelves cranial neural crest cell-derived mesenchymal protu- <br /> and neonatal death. The occurrence phenotype                    berances covered ectoderm-derived epithelium [38,39], and <br /> affected genetic background, increasing 50%                   alterations growth, proliferation, movement, adhesion and <br /> C57BL/6JX129/SvJ background 90% pure C57BL/6J                          death cells composing palatal structures affect palate <br /> background. We note 30% Tks5a/Tks5long pups                          architecture [37]. We previously demonstrated Tks5 and <br /> produced mixed genetic background died neonatal                    phosphorylation Src necessary neural crest cell <br /> period cleft palate evident; reason             migration vitro zebrafish embryos, disruption of <br /> would require investigation. In humans, clefts lip            Tks5 causes aberrant formation ceratobranchials, palato- <br /> palate frequent craniofacial defect affecting 1 700              quadrate, ethmoid plate Meckel&#226;&#8364;&#8482;s cartilage, cranial neural <br /> births, and, rarely lethal, associated                    crest cell-derived structures [24]. Thus, possible that, the <br /> significant morbidity financial cost derived corrective                 mouse Tks5a/Tks5long involved migration cranial neural <br /> surgeries dental, speech psychological treatments                        crest cells derivatives, affecting palatogenesis absent. <br />                                                                                  Given Tks5 essential invadosome formation, including <br />  <br />  <br /> PLOS ONE | www.plosone.org                                                  10                       September 2014 | Volume 9 | Issue 9 | e107674 <br />                                                                                                                         Alternative Isoforms Tks5 <br />  <br />  <br /> podosomes neural crest cells [24], cell structures          SH3 domain, lacking PX domain. These be <br /> are important cell migration [12], hypothesize absence             driven second promoter that, based findings, be <br /> of Tks5a/Tks5long disrupt podosome formation                     located intron V, rule existence of <br /> palatogenesis affecting cell migration ultimately leading              promoters intron VI VII [31]. The existence of <br /> cleft palate. Accordingly, absence invadosome proteins            alternative promoters mammalian genes fairly common <br /> vivo causes cleft palate. Loss Filamin A, required            event, estimated frequency 30 50% human genes <br /> podosome stabilization macrophage mesenchymal migra-                   [47,48,49] 50% mouse genes [50]. Their presence more <br /> tion [40] localizes podosomes osteoclasts [41]               frequent genes involved development [50] signal <br /> invadopodia oral carcinoma cells [42], associated cleft            transduction [47], possibly allowing generation multiple <br /> palate mice [43] humans [44]. Likewise, TGFb2 knock-                tuned transcripts single gene loci diverse functional, <br /> out mice present cleft palate array defects affecting        temporal and/or spatial requirements. Importantly, abnormal use <br /> neural crest-derived structures [45]. TGFb2 recently                 alternative promoters associated cancer [51]. In <br /> described induce podosomes human trabecular meshwork                    regard, altered balance Tks5short Tks5a/ <br /> cells [46]. The present study reveals general role            Tks5long expression linked poor prognosis human <br /> Tks adaptor function mammalian development,                    lung cancer [31], possible Tks5b also <br /> when proteins absent fetuses die utero post-                      role tumor suppression. <br /> implantation, sharp contrast Mendelian ratios achieved               Alternative splicing contribute substantially the <br /> at birth mice mutant Tks5a/Tks5long Tks4 [23].              diversity Tks5 transcripts. Exons 7 10 subject to <br /> Future work needed discern Tks4 Tks5                   alternative splicing [9]. Although predominant forms for <br /> compensatory redundant roles development [27],               Tks5a/Tks5long Tks5b mouse tissues cells ones <br /> podosomes involved Tks4 Tks5 developmental                         lacking exon 7 containing exon 10, existence ESTs <br /> functions mammals.                                                         DC332430, FLJ56087 XM_003255430.1, exon 7 but <br />    The second main finding described identification          exon 10, demonstrates alternative splicing <br /> novel Tks5 isoform, named Tks5b, lacking PX-domain. We                    isoforms exist. Together, findings indicate transcriptional <br /> identified Tks5b based following evidence: a)                 complexity sh3pxd2a locus, potentially originate <br /> highest molecular weight band missing characteristic             12 different mRNA transcripts alternative splicing and <br /> Tks5 triplet extracts MEFs homozygous trapping                possibly alternative promoter usage. If existence second <br /> mutation; b) identified human ESTs GenBank                  promoter confirmed, number potential sh3pxd2a <br /> database, DC332430 BP219917, 59 end 134 bp                    transcripts likely reduced, shown <br /> and 119 bp, respectively, upstream beginning exon 6,            activity alternative promoters conditions alternative <br /> both possess in-frame ATG codon located 29 bp upstream                  splicing [52,53]. In case, remains elucidated the <br /> the beginning exon, indicating encode proteins             potential sh3pxd2a transcripts vivo, and, case, <br /> amino terminus starts intron V, lacking PX-                  translated Tks5 protein isoforms. <br /> domain. Based high homology human                             The short size unique distinctive sequence Tks5b (29 <br /> SH3PXD2A mouse sh3pxd2a genes, designed 59RACE                       bp/10 amino acids) impedes generation specific molecular <br /> strategy yielded transcript mouse NIH3T3 fibroblasts                tools, riboprobe antibody, facilitate its <br /> whose coding sequence started ATG codon 29 bp                     study. However, unique sequence long design <br /> upstream exon 6. We concluded 29 bp sequence exon 6                  primers specific detection mRNA, expression we <br /> form new 58 bp-long exon named exon 6b, encoding amino                  analyzed adult mouse tissues MEFs. We detected Tks5b in <br /> terminus new isoform named Tks5b. The fact               tissues analyzed, relative expression Tks5a/ <br /> been able isolate 59RACE clone specifically detect Tks5b             Tks5long expression 490 8 times lower. This <br /> mRNA mouse tissues RT-qPCR strongly points                       indicates basal expression mRNAs isoforms very <br /> existence second alternative promoter located intron V. In            different tissues suggests specific tissue-dependent <br /> support this, able identify CpG island                   regulation isoform. Interestingly, detected Tks5b <br /> containing SP1 transcription factor binding site consensus            mRNA expression tissues Tks5a/Tks5long null adult <br /> sequences 2400 bp beginning exon 6b (data                  mice, Tks5a/Tks5long mRNA expression mice was <br /> not shown). Also, identified 2 GenBank ESTs                     absent near undetectable, expected. Notably, comparison of <br /> sequences human (FLJ56087) gibbon (XM_003255430.1),                    Tks5b mRNA expression wild type null mice tissues <br /> with 59 end starting 131 bp upstream beginning exon               suggest cross-regulation Tks5a/Tks5long Tks5b <br /> 6b. Curiously, coding sequence 2 ESTs located +               transcript abundance. That cross-regulation tissue specific, <br /> 5bp exon 6 continues 21 bp sequence intron VI              liver spleen wild-type mice increased expression <br /> just upstream beginning exon 7, suggesting existence          Tks5b mRNA, hearts mutant mice increased <br /> new exon 65 bp-long containing exon 7 21 bp upstream                  Tks5b mRNA expression respect wild-types, rest of <br /> sequence. We add data existence Tks5short,            tissues analyzed similar expression regardless Tks5a/ <br /> another PX domain-lacking isoform identified mouse starts             Tks5long presence. While auto-regulation gene expression a <br /> with unique sequence located intron VII contains exons 8             common phenomenon conserved biology [54], by <br /> to 15. 59RACE chromatin immunoprecipitation sequencing                    affecting transcription [55] mRNA stability [56,57], there <br /> experiments suggest form transcribed different                 examples describing different protein isoforms originating <br /> promoter originating Tks5a/Tks5long isoform                  locus modulate other&#226;&#8364;&#8482;s biological functions <br /> [31]. Together, evidence points existence second         [58], examples isoform cross-regulation the <br /> transcription initiation site hotspot sh3pxd2a gene,                   transcriptional mRNA processing levels. More experiments are <br /> maintained mammalian orthologues located                   needed define precise tissue cellular expression Tks5b <br /> intron V exon 8, originate multiple isoforms              different physiological pathological conditions, as <br /> with different short linear motif immediately preceding           factors controlling expression. <br />  <br />  <br /> PLOS ONE | www.plosone.org                                               11                      September 2014 | Volume 9 | Issue 9 | e107674 <br />                                                                                                                                                    Alternative Isoforms Tks5 <br />  <br />  <br />    We cloned mouse Tks5b form verified                                       manner Src master regulator relative <br /> corresponds 130 140 kDa bands detect                                        abundance Tks5a/Tks5long Tks5b isoforms post- <br /> immunoblotting endogenous Tks5 proteins. The over-                                    translational level. In contrast, overexpressed Tks5short protein <br /> expressed Tks5short corresponds 140 kDa band                                does affected presence active Src. The <br /> Src-transformed cells. From studies, however,                                  biochemical bases difference protein stability between <br /> assign specific identity lower bands cellular                         Tks5b Tks5short isoforms currently unknown. In the <br /> background and/or post-transcriptional modifications (e.g. phos-                             future, interesting address differential <br /> phorylation ubiquitination) affect mobility PX-                            expression Tks5a/Tks5long Tks5b isoforms play role <br /> lacking Tks5 forms. Furthermore, band correspond                                 Src-driven physiological pathological processes bone <br /> more isoform and/or post-translational modifica-                              remodeling [64], embryonic stem cell differentiation [65] and <br /> tions. Future analysis genomic regulation sh3pxd2a gene                            cancer [66]. <br /> will help elucidate precise mechanism Tks5 isoform                                       In summary, findings demonstrate essential role for <br /> expression. We determine vitro Tks5b protein                                   Tks5a/Tks5long mouse development existence of <br /> stability regulated Src activity. Src-transformation                                Tks5b, novel truncated isoform sh3pxd2a gene. The <br /> NIH3T3 fibroblasts MEFs causes increased expression                                 occurrence Tks5a/Tks5long Tks5b, Tks5short <br /> the 150 kDa band Tks5 triplet (Tks5a/Tks5long) near                             ESTs predicted translate PX domain-lacking <br /> disappearance 140 130 kDa bands,                                        Tks5 isoforms, indicates transcriptional complexity the <br /> abrogated treatment Src-kinase family inhibitors. Tks5                            sh3pxd2a gene, appears conserved mammalian <br /> was originally cloned library screen new Src substrates                           species. Such array isoforms hint multiple and <br /> [9], phosphorylation sites Tyr557 Tyr619 targeted                             fine-tuned functions Tks5 cell. Further experiments will <br /> Src activity present Tks5a/Tks5long Tks5b. Indeed,                             needed unveil regulatory pathways controlling the <br /> observed Tks5b isoform actively tyrosine-phosphorylated                           expression sh3pxd2a gene cellular functions and <br /> Src-transformed NIH3T3 cells, degree phosphor-                               biological implications of Tks5 isoforms. <br /> ylation correlates stability Tks5b, treatment with <br /> phosphatase caused increase Tks5b.                                       Acknowledgments <br /> Moreover, determined Tks5b targeted degradation <br />                                                                                              We thank Dr. Carolina Parada (University Southern California) for <br /> by proteasome. MG132 efficient epoxomicin and <br />                                                                                              helpful comments mouse palates, Emerald Butko (University of <br /> bortezomib assays, MG132 decreased                                  California, San Diego) assistance mouse experiments, Dr. Tyler <br /> <span id='am-163' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-164' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-165' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-166' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-167' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-168' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-169' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-170' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-171' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-172' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-173' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-174' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-175' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-176' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-177' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-178' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-179' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-180' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-181' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-182' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-183' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-184' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-185' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-186' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-187' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-188' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-189' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-190' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-191' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-192' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-193' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-194' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-195' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-196' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-197' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-198' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-199' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-200' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-201' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-202' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-203' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-204' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-205' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-206' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-207' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-208' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-209' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-210' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-211' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-212' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-213' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-214' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-215' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-216' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-217' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-218' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-219' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-220' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-221' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-222' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-223' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-224' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-225' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-226' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-228' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-229' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-231' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-232' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-233' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-234' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-235' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-236' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-237' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-238' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-239' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-240' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span>cell survival</span>. Taken together, hypothesize Src tyrosine-                             Jacks Carman Man-Chung Li (Massachusetts Institute Technology) <br /> phosphorylation Tks5b actively targets isoform                                   sharing reagents unpublished data. We grateful Chun-Teng <br /> degradation proteasome. Interestingly, Src kinase activity                            Huang SBMRI Viral Vector Core Facility Jorge Morales the <br /> can target number substrates degradation ubiquitin-                          SBMRI Animal Facility. We thank Christopher Abdullah Dr. Shinji <br /> proteasome pathway [59,60,61,62,63], direct tyrosine                               Iizuka critical reading manuscript. <br /> phosphorylation proteins degrade [60,62,63], or <br /> indirectly activation Ras-Raf-Mek1/2-Erk1/2                               Author Contributions <br /> pathway [61]. Therefore, results compatible                                 Conceived designed experiments: PCM AY NV PL BD SAC. <br /> hypothesis Src tyrosine phosphorylation Tks5b controls                           Performed experiments: PCM AY NV PL BD. Analyzed data: <br /> stability making substrate proteasome pathway. In                            PCM NV PL BD SAC. Wrote paper: PCM BD SAC. <br />  <br /> References <br />  1. Anderson KV, Ingham PW (2003) The transformation model organism:                      sarcoma virus. Proceedings National Academy Sciences United <br />     decade developmental genetics. Nature genetics 33 Suppl: 285&#226;&#8364;&#8220;293.                           States America 77: 6687&#226;&#8364;&#8220;6691. <br />  2. Matzuk MM, Burns KH (2012) Genetics mammalian reproduction: modeling                  14.   Gatesman A, Walker VG, Baisden JM, Weed SA, Flynn DC (2004) Protein <br />     end germline. Annual review physiology 74: 503&#226;&#8364;&#8220;528.                              kinase Calpha activates c-Src induces podosome formation AFAP-110. <br />  3. Davidson LA, Baum B (2012) Making waves: rise fall rise                         Molecular cellular biology 24: 7578&#226;&#8364;&#8220;7597. <br />     quantitative developmental biology. Development 139: 3065&#226;&#8364;&#8220;3069.                          15.   Tarone G, Cirillo D, Giancotti FG, Comoglio PM, Marchisio PC (1985) Rous <br />  4. Hanahan D, Weinberg RA (2011) Hallmarks cancer: generation. Cell                   sarcoma virus-transformed fibroblasts adhere primarily discrete protrusions of <br />     144: 646&#226;&#8364;&#8220;674.                                                                                  ventral membrane called podosomes. Experimental cell research 159: 141&#226;&#8364;&#8220; <br />  5. Copp AJ, Greene ND (2010) Genetics development neural tube defects.                     157. <br />     The Journal pathology 220: 217&#226;&#8364;&#8220;230.                                                   16.   Tatin F, Varon C, Genot E, Moreau V (2006) A signalling cascade involving <br />  6. Wessels MW, Willems PJ (2010) Genetic factors non-syndromic congenital                      PKC, Src Cdc42 regulates podosome assembly cultured endothelial cells <br />     heart malformations. Clinical genetics 78: 103&#226;&#8364;&#8220;123.                                            response phorbol ester. Journal cell science 119: 769&#226;&#8364;&#8220;781. <br />  7. Dixon MJ, Marazita ML, Beaty TH, Murray JC (2011) Cleft lip palate:                  17.   Destaing O, Sanjay A, Itzstein C, Horne WC, Toomre D, et al. (2008) The <br />     understanding genetic environmental influences. Nature reviews Genetics                    tyrosine kinase activity c-Src regulates actin dynamics organization of <br />     12: 167&#226;&#8364;&#8220;178.                                                                                   podosomes osteoclasts. Molecular biology cell 19: 394&#226;&#8364;&#8220;404. <br />  8. Parada C, Chai Y (2012) Roles BMP signaling pathway lip palate                 18.   Oikawa T, Itoh T, Takenawa T (2008) Sequential signals podosome <br />     development. Frontiers oral biology 16: 60&#226;&#8364;&#8220;70.                                              formation NIH-src cells. The Journal cell biology 182: 157&#226;&#8364;&#8220;169. <br />  9. Lock P, Abram CL, Gibson T, Courtneidge SA (1998) A new method                       19.   Abram CL, Seals DF, Pass I, Salinsky D, Maurer L, et al. (2003) The adaptor <br />     isolating tyrosine kinase substrates used identify fish, SH3 PX domain-              protein fish associates members ADAMs family localizes to <br />     containing protein, Src substrate. The EMBO journal 17: 4346&#226;&#8364;&#8220;4357.                         podosomes Src-transformed cells. The Journal biological chemistry 278: <br /> 10. Stylli SS, Stacey TT, Verhagen AM, Xu SS, Pass I, et al. (2009) Nck adaptor                    16844&#226;&#8364;&#8220;16851. <br />     proteins link Tks5 invadopodia actin regulation ECM degradation.                  20.   Diaz B, Shani G, Pass I, Anderson D, Quintavalle M, et al. (2009) Tks5- <br />     Journal cell science 122: 2727&#226;&#8364;&#8220;2740.                                                        dependent, nox-mediated generation reactive oxygen species necessary for <br /> 11. Seals DF, Azucena EF Jr, Pass I, Tesfay L, Gordon R, et al. (2005) The adaptor                 invadopodia formation. Science signaling 2: ra53. <br />     protein Tks5/Fish required podosome formation function,           21.   Diaz B, Courtneidge SA (2012) Redox signaling invasive microdomains in <br />     protease-driven invasion cancer cells. Cancer cell 7: 155&#226;&#8364;&#8220;165.                              cancer cells. Free radical biology &amp; medicine 52: 247&#226;&#8364;&#8220;256. <br /> 12. Murphy DA, Courtneidge SA (2011) The &#226;&#8364;&#8482;ins&#226;&#8364;&#8482; &#226;&#8364;&#8482;outs&#226;&#8364;&#8482; podosomes                   22.   Buschman MD, Bromann PA, Cejudo-Martin P, Wen F, Pass I, et al. (2009) The <br />     invadopodia: characteristics, formation function. Nature reviews Molecular                 novel adaptor protein Tks4 (SH3PXD2B) required functional podosome <br />     cell biology 12: 413&#226;&#8364;&#8220;426.                                                                      formation. Molecular biology cell 20: 1302&#226;&#8364;&#8220;1311. <br /> 13. David-Pfeuty T, Singer SJ (1980) Altered distributions cytoskeletal               23.   Iqbal Z, Cejudo-Martin P, Brouwer A, van der Zwaag B, Ruiz-Lozano P, et <br />     proteins vinculin alpha-actinin cultured fibroblasts transformed Rous                al. (2010) Disruption podosome adaptor protein TKS4 (SH3PXD2B) <br />  <br />  <br />  <br /> PLOS ONE | www.plosone.org                                                              12                            September 2014 | Volume 9 | Issue 9 | e107674 <br />                                                                                                                                                       Alternative Isoforms Tks5 <br />  <br />  <br />       causes skeletal dysplasia, eye, cardiac abnormalities Frank-Ter Haar             45. Sanford LP, Ormsby I, Gittenberger-de Groot AC, Sariola H, Friedman R, et <br />       Syndrome. American journal human genetics 86: 254&#226;&#8364;&#8220;261.                                       al. (1997) TGFbeta2 <span id='am-397' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-398' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-399' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-400' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-401' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-402' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-403' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-404' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-405' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-406' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-407' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-408' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-409' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-410' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-411' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-412' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-413' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-414' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-415' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-416' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-417' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-418' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-419' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-420' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-421' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-422' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-423' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-424' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-425' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-426' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-427' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-428' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-429' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-430' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-431' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-432' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-433' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-434' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-435' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-436' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-437' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-438' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-439' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-440' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-441' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-442' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-443' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-444' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-445' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-446' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-447' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-448' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-449' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-450' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-451' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-452' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-453' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-454' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-455' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-456' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-457' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-458' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-459' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-460' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-461' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-462' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-463' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-464' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-465' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-466' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-467' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-468' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-469' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-470' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-471' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-472' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-473' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-474' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span>knockout</span> mice multiple developmental defects are <br /> 24.   Murphy DA, Diaz B, Bromann PA, Tsai JH, Kawakami Y, et al. (2011) A Src-                        non-overlapping TGFbeta knockout phenotypes. Development 124: <br />       Tks5 pathway required neural crest cell migration embryonic                       2659&#226;&#8364;&#8220;2670. <br />       development. PloS 6: e22499.                                                            46. Han H, Kampik D, Grehn F, Schlunck G (2013) TGF-beta2-induced <br /> 25.   Rosenthal N, Brown S (2007) The mouse ascending: perspectives human-                        invadosomes human trabecular meshwork cells. PloS 8: e70595. <br />       disease models. Nature cell biology 9: 993&#226;&#8364;&#8220;999.                                             47. Kimura K, Wakamatsu A, Suzuki Y, Ota T, Nishikawa T, et al. (2006) <br /> 26.   Schofield PN, Hoehndorf R, Gkoutos GV (2012) Mouse genetic phenotypic                       Diversification transcriptional modulation: large-scale identification and <br />       resources human genetics. Human mutation 33: 826&#226;&#8364;&#8220;836.                                       characterization putative alternative promoters human genes. Genome <br /> 27.   Thyagarajan T, Totey S, Danton MJ, Kulkarni AB (2003) Genetically altered                       research 16: 55&#226;&#8364;&#8220;65. <br />       mouse models: good, bad, ugly. Critical reviews oral biology             48. Kim TH, Barrera LO, Zheng M, Qu C, Singer MA, et al. (2005) A high- <br />       medicine: official publication American Association Oral                       resolution map active promoters human genome. Nature 436: 876&#226;&#8364;&#8220;880. <br />       Biologists 14: 154&#226;&#8364;&#8220;174.                                                                     49. Cooper SJ, Trinklein ND, Anton ED, Nguyen L, Myers RM (2006) <br /> 28.   Jeong YJ, Choi HW, Shin HS, Cui XS, Kim NH, et al. (2005) Optimization                       Comprehensive analysis transcriptional promoter structure function in <br />       real time RT-PCR methods analysis gene expression mouse eggs <br />                                                                                                       1% human genome. Genome research 16: 1&#226;&#8364;&#8220;10. <br />       preimplantation embryos. Molecular reproduction development 71: <br />                                                                                                   50. Baek D, Davis C, Ewing B, Gordon D, Green P (2007) Characterization and <br />       284&#226;&#8364;&#8220;289. <br />                                                                                                       predictive discovery evolutionarily conserved mammalian alternative <br /> 29.   Laird AD, Li G, Moss KG, Blake RA, Broome MA, et al. (2003) Src family <br />                                                                                                       promoters. Genome research 17: 145&#226;&#8364;&#8220;155. <br />       kinase activity required signal tranducer activator transcription 3 <br />       focal adhesion kinase phosphorylation vascular endothelial growth                   51. Davuluri RV, Suzuki Y, Sugano S, Plass C, Huang TH (2008) The functional <br />       factor signaling vivo anchorage-dependent -independent growth                    consequences alternative promoter use mammalian genomes. Trends in <br />       human tumor cells. Molecular cancer therapeutics 2: 461&#226;&#8364;&#8220;469.                                <br /> </body></html>